TITLE

Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five - year retrospective study

AUTHOR(S)
Tessema, Belay; Muche, Abebe; Bekele, Assegedech; Reissig, Dieter; Emmrich, Frank; Sack, Ulrich
PUB. DATE
January 2009
SOURCE
BMC Public Health;2009, Vol. 9, p371
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In Gondar University Teaching Hospital standardized tuberculosis prevention and control programme, incorporating Directly Observed Treatment, Short Course (DOTS) started in 2000. According to the proposal of World Health Organization (WHO), treatment outcome is an important indicator of tuberculosis control programs. This study investigated the outcome of tuberculosis treatment at Gondar University Teaching Hospital in Northwest Ethiopia. Methods: We analyzed the records of 4000 tuberculosis patients registered at Gondar University Teaching Hospital from September 2003 to May 2008. Treatment outcome and tuberculosis type were categorized according to the national tuberculosis control program guideline. Multivariate analysis using logistic regression model was used to analyse the association between treatment outcome and potential predictor variables. Results: From the total of 4000 patients, tuberculosis type was categorized as extrapulmonary in 1133 (28.3%), smear negative pulmonary tuberculosis in 2196 (54.9%) and smear positive pulmonary tuberculosis in 671 (16.8%) cases. Of all patients, treatment outcome was classified as successfully treated in 1181(29.5%), defaulted in 730 (18.3%), died in 403 (10.1%), treatment failed in six (0.2%) and transferred out in 1680 (42.0%) patients. Males had the trend to be more likely to experience death or default than females, and the elderly were more likely to die than younger. The proportion of default rate was increased across the years from 97(9.2%) to 228(42.9%). Being female, age group 15-24 years, smear positive pulmonary tuberculosis and being urban resident were associated with higher treatment success rate. Conclusion: The treatment success rate of tuberculosis patients was unsatisfactorily low (29.5%). A high proportion of patients died (10.1%) or defaulted (18.3%), which is a serious public health concern that needs to be addressed urgently.
ACCESSION #
45197534

 

Related Articles

  • Five-years experiences of the Revised National Tuberculosis Control Programme in northern part of Kolkata, India. Pandit, Sudipta; Dey, Atin; Chaudhuri, Arunabha Datta; Saha, Mita; Sengupta, Amitava; Kundu, Sushmita; Bhuniya, Sourin; Shib Singh // Lung India;2009, Vol. 26 Issue 4, p109 

    Background: The Revised National Tuberculosis Control programme (RNTCP), India. Aim: To assess the impact of the expansion of the RNTCP in the case detection and treatment outcome. Materials and Methods: Reports of patients with tuberculosis (TB) diagnosed and treated under RNTCP from 2001 to...

  • Treatment outcome of extra-pulmonary tuberculosis in Finland: a cohort study. Vasankari, Tuula; Holmström, Pekka; Ollgren, Jukka; Liippo, Kari; Ruutu, Petri // BMC Public Health;2010, Vol. 10, p399 

    Background: We investigated the treatments given, the outcome and the patient- and treatment-system dependent factors affecting treatment outcome in a national two-year cohort of culture-verified extra-pulmonary tuberculosis cases in Finland. Methods: Medical records of all cases in 1995 -1996...

  • A comparison between passive and active case finding in TB control in the Arkhangelsk region. Kuznetsov, Vladimir N.; Grjibovski, Andrej M.; Mariandyshev, Andrey O.; Johansson, Eva; Bjune, Gunnar A. // International Journal of Circumpolar Health;2014, Vol. 73, p1 

    Background. In Russia, active case finding (ACF) for certain population groups has been practiced uninterruptedly for many decades, but no studies comparing ACF and passive case finding (PCF) approaches in Russia have been published. Objective. The aim of this study was to describe the main...

  • Multidrug resistant to extensively drug resistant tuberculosis: What is next? Jain, Amita; Dixit, Pratima // Journal of Biosciences;Nov2008, Vol. 33 Issue 4, p605 

    Drug resistant tuberculosis is a man made problem. While tuberculosis is hundred percent curable, multidrug resistant tuberculosis (MDR-TB) is difficult to treat. Inadequate and incomplete treatment and poor treatment adherence has led to a newer form of drug resistance known as extensively drug...

  • Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. Sei Won Lee; Choon-Taek Lee; Jae-Joon Yim // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p300 

    Background: The role of interferon-γ release assay (IGRA) in monitoring responses to anti-tuberculosis (TB) treatment is not clear. We evaluated the results of the QuantiFERON-TB Gold In-tube (QFT-GIT) assay over time during the anti-TB treatment of adults with no underlying disease. Methods:...

  • Sternal wound tuberculosis following cardiac operations: a review. Shi-Min Yuan // Brazilian Journal of Cardiovascular Surgery;2015, Vol. 30 Issue 4, p489 

    Objective: The diagnosis and treatment of sternal wound infections with mycobacteria are challenging. Such an infection is often associated with a delayed diagnosis and improper treatment that may lead to a worsened clinical outcome. The present study is designed to highlight its clinical...

  • How does my doctor treat TB infection?  // Tuberculosis: Getting Healthy, Staying Healthy;Jun2008, Issue 8, p6 

    The article provides an answer to a question of how physicians treat tuberculosis (TB) infection.

  • A waiting room from hell. Sonkar, Madhulika // Asian Pacific Post;10/27/2011, p16 

    The article focuses on the case of 17-year-old Shehnaz, who has stayed outside the All India Institute of Medical Sciences (AIIMS) in New Delhi, India for 40 days just to be told by doctors that her bone tuberculosis is incurable.

  • New tuberculosis tests reduce diagnostic costs.  // PharmacoEconomics & Outcomes News;Mar2015, Vol. 724 Issue 1, p20 

    The article reports that using novel diagnostics for treating tuberculosis would reduce diagnostic costs.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics